Dr. Deliyannides is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
The Zucker Hillside Hospital Addiction Rec Serv
7559 263RD Street Littauer Building
Glen Oaks, NY 11004Phone+1 718-470-8929
Education & Training
- New York Presbyterian Hospital (Cornell Campus)/WestchesterResidency, Psychiatry, 1985 - 1989
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1985
Certifications & Licensure
- CT State Medical License 1994 - 2026
- NY State Medical License 1986 - 2025
- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology
Clinical Trials
- Tranylcypromine Treatment of Bipolar Depression Start of enrollment: 2011 Nov 01
Publications & Presentations
PubMed
- 17 citationsA randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.David J. Hellerstein, Jonathan W. Stewart, Patrick J. McGrath, Deborah A. Deliyannides, Sarai T. Batchelder
The Journal of Clinical Psychiatry. 2012-07-15 - 16 citationsCan people with nonsevere major depression benefit from antidepressant medicationJessica A. Stewart, Deborah A. Deliyannides, David J. Hellerstein, Patrick J. McGrath, Jonathan W. Stewart
The Journal of Clinical Psychiatry. 2012-04-01 - 4 citationsIs duloxetine effective treatment for depression with atypical featuresJonathan W. Stewart, Deborah A. Deliyannides, Patrick J. McGrath
International Clinical Psychopharmacology. 2008-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: